Gennex Laboratories Approves Unaudited Q2 FY27 Results

Gennex Laboratories Limited announced that its Board of Directors, in a meeting held on November 14, 2026, approved the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The company reported a net profit of ₹335.15 Lakhs for the quarter ended September 30, 2026, compared to ₹453.32 Lakhs in the same period last year. For the half-year ended September 30, 2026, the net profit stood at ₹730.68 Lakhs, a decrease from ₹868.27 Lakhs in the corresponding period of the previous year. The Board also approved limited review reports from the statutory auditor, reconstituted the Audit Committee, Nomination & Remuneration Committee, and Stakeholders Relationship Committee, and dissolved the Rights Issue Committee. The meeting commenced at 4:00 PM and concluded at 6:00 PM.